Lustig, Kevin, PhD

CEO, Assay Depot


Kevin co-founded the Assay Depot. His last position was co-founder, first employee and research director at Kalypsys, a biopharmaceutical company that has raised over $300 million and has multiple drug candidates in the clinic. Prior to Kalypsys, Kevin was a research director at Tularik, a biopharmaceutical company that was purchased by Amgen for more than $2.5 billion. He carried out postdoctoral work at Harvard Medical School after receiving a PhD degree from Marc Kirschner's laboratory at the University of California, San Francisco (UCSF). Kevin received an A.B. degree magna cum laude from Cornell University's College of Arts and Sciences in 1985.

Listen to an interview with Kevin